Prenostics is on a mission to make cancer predictable and preventable.
As a professor of cancer research at the University of Oxford and a practicing oncologist, Prenostic's founder Sarah Blagden has worked for more than two decades to challenge the perception that cancer is unavoidable.
Her research revealed a new biomarker of precancer, a way of detecting the disease years in advance of it manifesting in the body.
This led to the launch of the Prenostics test, a blood test that identifies precancers.
You can learn more about Prenostics at our website.
Company Details
- Employees
- 3
- Founded
- 2015
- Address
- Oxford
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.prenostics.com/
- Keywords
- Cancer Detection.
- HQ
- Oxford
Prenostics Questions
Prenostics's website is https://www.prenostics.com/
Prenostics's LinkedIn profile is https://uk.linkedin.com/company/prenostics-limited
Prenostics has
3 employees.
View email and phone details for 3
employees at Prenostics.
Prenostics's industry is
Biotechnology Research
Prenostics's top competitors are
Jem Healthtech,
G Spot,
Studio Everywhere,
Cerevora Therapeutics Inc.,
Clensy & Co Ltd,
Pydantic,
Rair Health,
Seep,
Aerion Bioscience,
Valiblocks.
Prenostics's categories are Biotechnology Research
Prenostics's founding year is 2015
